# EDGAR Filing Document

**Accession Number:** 0000785786
**File Stem:** 0000785786-25-000045
**Filing Date:** 2025-7
**Character Count:** 44781
**Document Hash:** b53bcaa235b70a3acfc7fea1375f8728
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000785786-25-000045.hdr.sgml**: 20250723

**ACCESSION NUMBER**: 0000785786-25-000045

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 16

**CONFORMED PERIOD OF REPORT**: 20250723

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250723

**DATE AS OF CHANGE**: 20250723

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PLEXUS CORP
- **CENTRAL INDEX KEY:** 0000785786
- **STANDARD INDUSTRIAL CLASSIFICATION:** PRINTED CIRCUIT BOARDS [3672]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 391344447
- **STATE OF INCORPORATION:** WI
- **FISCAL YEAR END:** 0927

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14423
- **FILM NUMBER:** 251143371

**BUSINESS ADDRESS:**
- **STREET 1:** PLEXUS CORP
- **STREET 2:** ONE PLEXUS WAY
- **CITY:** NEENAH
- **STATE:** WI
- **ZIP:** 54956
- **BUSINESS PHONE:** 9209696000

**MAIL ADDRESS:**
- **STREET 1:** PLEXUS CORP
- **STREET 2:** ONE PLEXUS WAY
- **CITY:** NEENAH
- **STATE:** WI
- **ZIP:** 54956

?xml version='1.0' encoding='ASCII'? plxs-20250723

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**____________________________________________________________________________________________________________________________________**

FORM 8-K

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**____________________________________________________________________________________________________________________________________**

Date of Report (Date of earliest event reported): July 23, 2025

**____________________________________________________________________________________________________________________________________**

![plxslogo8ka05.gif](plxs-20250723_g1.gif)

**PLEXUS CORP.** 

(Exact name of registrant as specified in its charter)

**____________________________________________________________________________________________________________________________________**

---

| | | |
|:---|:---|:---|
| **Wisconsin** | **001-14423** | **39-1344447** |
| (State or other jurisdiction<br> of incorporation) | (Commission <br>File Number) | (IRS Employer <br>Identification No.) |

---

**One Plexus Way** 

**Neenah, Wisconsin 54957** 

(Address of principal executive offices) (Zip Code)

**Telephone Number (920) 969-6000** 

(Registrant's telephone number, including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of each exchange on which registered</u>** |
| Common Stock, $0.01 par value | PLXS | The Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp;☐

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;☐

------

**Item 2.02&nbsp;&nbsp;&nbsp;&nbsp;Results of Operations and Financial Condition.**

On July 23, 2025, Plexus Corp. ("we" or the "Company") announced results for the fiscal third quarter ended June 28, 2025. A copy of the Company's related press release is furnished as Exhibit 99.1 to this report.

**Item 9.01&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

(d) The following exhibits are filed herewith:

---

| | |
|:---|:---|
| Exhibit Number | Description |
| 99.1 | <u>[Press release issued by Plexus Corp., dated](plxsf25q3earningsrelease-e.htm)[July](plxsf25q3earningsrelease-e.htm)[23, 2025](plxsf25q3earningsrelease-e.htm)</u> |
| 104 | Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document) |

---

------

**\* \* \* \* \***

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| Date: July 23, 2025 | PLEXUS CORP. |
|  | (Registrant) |
|  | By: <u>/s/ Patrick J. Jermain</u> |
|  | Patrick J. Jermain |
|  | Executive Vice President and Chief Financial Officer |

---

## Exhibit 99.1

![plexusprlogo_1a.gif](plexusprlogo_1a.gif)

**Plexus Announces Fiscal Third Quarter Financial Results**

NEENAH, WI – July 23, 2025 - Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal third quarter ended June 28, 2025, and guidance for our fiscal fourth quarter ending September 27, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reports fiscal third quarter 2025 revenue of $1.018 billion, GAAP operating margin of 5.3% and GAAP diluted EPS of $1.64.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reports fiscal third quarter 2025 non-GAAP operating margin of 6.0% and non-GAAP diluted EPS of $1.90, excluding $0.26 of stock-based compensation expense.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Initiates fiscal fourth quarter 2025 revenue guidance of $1.025 billion to $1.065 billion with GAAP diluted EPS of $1.57 to $1.72, including $0.25 of stock-based compensation expense. Fiscal fourth quarter non-GAAP EPS guidance of $1.82 to $1.97 excludes stock-based compensation expense.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | Three Months Ended | Three Months Ended | Three Months Ended |
| | | Jun 28, 2025<br>Q3F25 Results | Jun 28, 2025<br>Q3F25 Guidance  | Sep 27, 2025<br>Q4F25 Guidance |
| **Summary GAAP Items** | **Summary GAAP Items** |  |  |  |
| Revenue (in billions) | Revenue (in billions) | $1.018 | $1.000 to $1.040 | $1.025 to $1.065 |
| Operating margin | Operating margin | 5.3% | 5.0% to 5.4% | 5.0% to 5.4% |
| Diluted EPS | Diluted EPS | $1.64 | $1.40 to $1.55 | $1.57 to $1.72 |
| **Summary Non-GAAP Items (1)** | **Summary Non-GAAP Items (1)** |  |  |  |
| Adjusted operating margin (2) | Adjusted operating margin (2) | 6.0% | 5.7% to 6.1% | 5.7% to 6.1% |
| Adjusted EPS (3) | Adjusted EPS (3) | $1.90 | $1.65 to $1.80 | $1.82 to $1.97 |
| Return on invested capital (ROIC) | Return on invested capital (ROIC) | 14.1% |  |  |
| Economic return | Economic return | 5.2% |  |  |
| *(1)* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* | *Refer to Non-GAAP Supplemental Information tables for additional information regarding non-GAAP financial measures.* |
| *(2)* | *Excludes stock-based compensation expense of approximately 70 bps for Q3F25 results, Q3F25 guidance and Q4F25 guidance.* | *Excludes stock-based compensation expense of approximately 70 bps for Q3F25 results, Q3F25 guidance and Q4F25 guidance.* | *Excludes stock-based compensation expense of approximately 70 bps for Q3F25 results, Q3F25 guidance and Q4F25 guidance.* | *Excludes stock-based compensation expense of approximately 70 bps for Q3F25 results, Q3F25 guidance and Q4F25 guidance.* |
| *(3)* | *Excludes stock-based compensation expense, net of tax, of $0.26 for Q3F25 results and $0.25 for Q3F25 guidance and Q4F25 guidance.* | *Excludes stock-based compensation expense, net of tax, of $0.26 for Q3F25 results and $0.25 for Q3F25 guidance and Q4F25 guidance.* | *Excludes stock-based compensation expense, net of tax, of $0.26 for Q3F25 results and $0.25 for Q3F25 guidance and Q4F25 guidance.* | *Excludes stock-based compensation expense, net of tax, of $0.26 for Q3F25 results and $0.25 for Q3F25 guidance and Q4F25 guidance.* |

---

**Fiscal Third Quarter 2025 Information**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Won 41 manufacturing programs during the quarter representing $250 million in annualized revenue when fully ramped into production.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Generated fiscal third quarter free cash flow of $13.2 million, contributing to fiscal year-to-date free cash flow of $56.8 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Purchased $18.4 million of our shares at an average price of $128.70 per share during the quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• As previously announced on May 14, 2025, Plexus' Board of Directors approved a new $100.0 million share repurchase program. Plexus has recently begun repurchasing shares under this $100.0 million program as the previous $50.0 million program has been fulfilled.

------

*Todd Kelsey, President and Chief Executive Officer, commented, "Our Plexus team continues to execute at a high level in driving numerous efficiency initiatives, which resulted in another strong quarter of financial performance. Fiscal third quarter revenue of $1.018 billion grew sequentially and was in-line with guidance, non-GAAP operating margin of 6.0% was near the high end of guidance and non-GAAP EPS of $1.90 exceeded guidance. Furthermore, free cash flow again surpassed our expectations."*

*Patrick Jermain, Executive Vice President and Chief Financial Officer, commented, "Fiscal third quarter cash cycle of 69 days was consistent with expectations and one day higher than the fiscal second quarter. For the sixth consecutive quarter, we drove a reduction in our gross inventory balance. This result, combined with other improvements to our cash cycle and our strong operating performance, produced fiscal third quarter return on invested capital of 14.1%, which exceeded our weighted average cost of capital by 520 basis points. We also delivered better than anticipated free cash flow of $13.2 million in support of our expectation to achieve approximately $100 million in free cash flow for fiscal 2025. Finally, furthering our commitment to return cash to our shareholders, we repurchased $18.4 million of our shares during the fiscal third quarter, while adding a $100 million share repurchase program to our previous, now fully-utilized, $50 million program."*

*Mr. Kelsey added, "Our go-to-market team secured 41 fiscal third quarter manufacturing wins with well-balanced market sector diversification, representing $250 million in annualized revenue. Included in these wins are share gains resulting from our sustained focus on zero defects and perfect delivery as well as new customers in each of our market sectors with products aligned to exciting growth technologies."*

*Mr. Kelsey concluded, "We are committed to creating long-term shareholder value through enabling customer success and focused initiatives that drive organizational and operational efficiency. We are bullish on the growth opportunities our solutions and market sectors provide. Our strategy is creating opportunities to gain share and capture new outsourcing opportunities in support of delivering sustained strong financial performance and growth exceeding that of our end markets."*

------

---

| | | | |
|:---|:---|:---|:---|
| **Quarterly Comparison** | Three Months Ended | Three Months Ended | Three Months Ended |
| *(in thousands, except EPS)* | Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 |
| Revenue | $1018308 | $980170 | $960751 |
| Gross profit | 103288 | 97751 | 94415 |
| Operating income | 53608 | 48791 | 39246 |
| Net income | 45116 | 39073 | 25140 |
| Diluted EPS | $1.64 | $1.41 | $0.91 |
| Gross margin | 10.1% | 10.0% | 9.8% |
| Operating margin | 5.3% | 5.0% | 4.1% |
| ROIC (1) | 14.1% | 13.7% | 10.4% |
| Economic return (1) | 5.2% | 4.8% | 2.2% |
| *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* | *(1) Refer to Non-GAAP Supplemental Information tables for non-GAAP financial measures discussed and/or disclosed in this release, such as adjusted operating margin, adjusted net income, adjusted diluted EPS, ROIC and economic return.* |

---

**Business Segment and Market Sector Revenue** 

Plexus measures operational performance and allocates resources on a geographic segment basis. Plexus also reports revenue based on the market sector breakout set forth in the table below, which reflects Plexus' market sector focused strategy. Top 10 customers comprised 48% of revenue during the third quarter of both fiscal 2025 and 2024, which is down three percentage points from the second quarter of fiscal 2025.

---

| | | | |
|:---|:---|:---|:---|
| **Business Segments ($ in millions)** | Three Months Ended | Three Months Ended | Three Months Ended |
|  | Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 |
| Americas | $312 | $295 | $306 |
| Asia-Pacific | 594 | 587 | 521 |
| Europe, Middle East and Africa | 117 | 103 | 137 |
| Elimination of inter-segment sales | (5) | (5) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1018 | $980 | $961 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Market Sectors ($ in millions)** | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended |
|  | Jun 28, 2025 | Jun 28, 2025 | Mar 29, 2025 | Mar 29, 2025 | Jun 29, 2024 | Jun 29, 2024 |
| Aerospace/Defense | $183 | 18% | $172 | 18% | $178 | 18% |
| Healthcare/Life Sciences | 420 | 41% | 411 | 42% | 380 | 40% |
| Industrial | 415 | 41% | 397 | 40% | 403 | 42% |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Revenue | $1018 |  | $980 |  | $961 |  |

---

------

**Non-GAAP Supplemental Information**

Plexus provides non-GAAP supplemental information, such as ROIC, economic return and free cash flow, because such measures are used for internal management goals and decision-making, and because they provide management and investors with additional insight into financial performance. In addition, management uses these and other non-GAAP measures, such as adjusted operating income, adjusted operating margin, adjusted net income and adjusted diluted EPS, to provide a better understanding of core performance for purposes of period-to-period comparisons. Plexus believes that these measures are also useful to investors because they provide further insight by eliminating the effect of non-recurring items that are not reflective of continuing operations. For additional information on non-GAAP measures, please refer to the attached Non-GAAP Supplemental Information tables.

**ROIC and Economic Return**

ROIC for the third quarter of fiscal 2025 was 14.1%. Plexus defines ROIC as tax-effected annualized adjusted operating income divided by average invested capital over a four-quarter period for the third fiscal quarter. Invested capital is defined as equity plus debt and operating lease obligations, less cash and cash equivalents. Plexus' weighted average cost of capital for fiscal 2025 is 8.9%. ROIC for the third quarter of fiscal 2025 less Plexus' weighted average cost of capital resulted in an economic return of 5.2%.

**Free Cash Flow**

Plexus defines free cash flow as cash flows provided by operations less capital expenditures. For the three months ended June 28, 2025, cash flows provided by operations was $26.9 million, less capital expenditures of $13.7 million, resulting in free cash flow of $13.2 million.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Cash Cycle Days** | **Cash Cycle Days** | Three Months Ended | Three Months Ended | Three Months Ended |
|  |  | Jun 28, 2025 | Mar 29, 2025 | Jun 29, 2024 |
| Days in Accounts Receivable | Days in Accounts Receivable | 59 | 57 | 61 |
| Days in Contract Assets | Days in Contract Assets | 13 | 12 | 11 |
| Days in Inventory | Days in Inventory | 128 | 132 | 151 |
| Days in Accounts Payable | Days in Accounts Payable | (72) | (70) | (62) |
| Days in Advanced Payments | Days in Advanced Payments | (59) | (63) | (78) |
| &nbsp;&nbsp;&nbsp;&nbsp;Annualized Cash Cycle (1) | &nbsp;&nbsp;&nbsp;&nbsp;Annualized Cash Cycle (1) | 69 | 68 | 83 |
| *(1)* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* | *Plexus calculates cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in advanced payments.* |

---

------

**Conference Call and Webcast Information**

---

| | |
|:---|:---|
| **What:**  | Plexus Fiscal 2025 Q3 Earnings Conference Call and Webcast |
| **When:**  | Thursday, July 24, 2025 at 8:30 a.m. Eastern Time |
| **Where:**  | Participants are encouraged to join the live webcast at the investor relations section of the Plexus website, plexus.com. Participants can also join utilizing the links below:<br>Webcast link:<br>https://events.q4inc.com/attendee/103729490 |
| **Replay:**  | The webcast will be archived on the Plexus website and will be available as on-demand for 12 months |

---

**Investor and Media Contact**

Shawn Harrison

+1.920.969.6325

shawn.harrison@plexus.com

**About Plexus**

Since 1979, Plexus has helped create the products that build a better world. Driven by a passion for excellence, we partner with our customers to design, manufacture and service highly complex products in demanding regulatory environments. From life-saving medical devices and mission-critical aerospace and defense products to industrial automation systems and semiconductor capital equipment, our innovative solutions across the lifecycle of a product converge where advanced technology and human impact intersect. We provide these solutions to market-leading as well as disruptive global companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors, supported by a global team of over 20,000 members across our 26 facilities in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions. For more information about Plexus, visit our website at www.plexus.com.

**Safe Harbor and Fair Disclosure Statement** 

*The statements contained in this press release that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the outcome of litigation and regulatory investigations and proceedings, including the results of any challenges with regard to such outcomes; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and regulatory matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, conflict in the Middle East, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2024 Form 10-K.*

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** | **CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS** |
| (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) |
|  | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
|  | Jun 28, | Jun 29, | Jun 28, | Jun 29, |
|  | 2025 | 2024 | 2025 | 2024 |
| Net sales | $1018308 | $960751 | $2974600 | $2910258 |
| Cost of sales | 915020 | 866336 | 2672869 | 2639640 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 103288 | 94415 | 301731 | 270618 |
| Operating expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling and administrative expenses | 49680 | 45950 | 147789 | 136487 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and other charges, net |  | 9219 | 4683 | 20257 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating income | 53608 | 39246 | 149259 | 113874 |
| Other income (expense): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (2501) | (7389) | (9192) | (23299) |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income | 934 | 1015 | 3039 | 2640 |
| &nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous, net | (2205) | (2568) | (4753) | (9097) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income before income taxes | 49836 | 30304 | 138353 | 84118 |
| Income tax expense | 4720 | 5164 | 16897 | 13524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $45116 | $25140 | $121456 | $70594 |
| Earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.67 | $0.92 | $4.48 | $2.57 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.64 | $0.91 | $4.39 | $2.53 |
| Weighted average shares outstanding: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 27059 | 27364 | 27084 | 27463 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 27532 | 27765 | 27670 | 27918 |

---

------

---

| | | |
|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** | **CONDENSED CONSOLIDATED BALANCE SHEETS** |
| (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) |
| (unaudited) | (unaudited) | (unaudited) |
|  | Jun 28, | Sep 28, |
|  | 2025 | 2024 |
| **ASSETS** |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $237567 | $345109 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 50 | 2353 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 663549 | 622366 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract assets | 145145 | 120560 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 1278219 | 1311434 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | 70538 | 75328 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 2395068 | 2477150 |
| Property, plant and equipment, net | 534560 | 501112 |
| Operating lease right-of-use assets | 74741 | 74360 |
| Deferred income taxes | 73550 | 73919 |
| Other assets | 27714 | 27280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-current assets | 710565 | 676671 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $3105633 | $3153821 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt and finance lease obligations | $50678 | $157325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 722270 | 606378 |
| &nbsp;&nbsp;&nbsp;&nbsp;Advanced payments from customers | 592512 | 709152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued salaries and wages | 89797 | 94448 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other accrued liabilities | 61196 | 75991 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 1516453 | 1643294 |
| Long-term debt and finance lease obligations, net of current portion | 92215 | 89993 |
| Accrued income taxes payable |  | 17198 |
| Long-term operating lease liabilities | 31192 | 32275 |
| Deferred income taxes | 5986 | 8234 |
| Other liabilities | 40702 | 38002 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total non-current liabilities | 170095 | 185702 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1686548 | 1828996 |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 547 | 545 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in-capital | 688002 | 680638 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock held in treasury | (1233922) | (1190115) |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 1944599 | 1823143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 19859 | 10614 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 1419085 | 1324825 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $3105633 | $3153821 |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 1** |
| (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) | (in thousands, except per share data) |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) |
|  |  | Three Months Ended | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
|  |  | Jun 28, | Mar 29, | Jun 29, | Jun 28, | Jun 29, |
|  |  | 2025 | 2025 | 2024 | 2025 | 2024 |
| Operating income, as reported | Operating income, as reported | $53608 | $48791 | $39246 | $149259 | $113874 |
| Operating margin, as reported | Operating margin, as reported | 5.3% | 5.0% | 4.1% | 5.0% | 3.9% |
| Non-GAAP adjustments: | Non-GAAP adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs (1) | &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs (1) |  |  | 9219 | 4683 | 22507 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income (2) | &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income (2) |  |  |  |  | (2250) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 7691 | 7132 | 7205 | 21813 | 19636 |
| Non-GAAP operating income | Non-GAAP operating income | $61299 | $55923 | $55670 | $175755 | $153767 |
| Non-GAAP operating margin | Non-GAAP operating margin | 6.0% | 5.7% | 5.8% | 5.9% | 5.3% |
| Net income, as reported | Net income, as reported | $45116 | $39073 | $25140 | $121456 | $70594 |
| Non-GAAP adjustments: | Non-GAAP adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) | &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) |  |  | 8251 | 4191 | 20144 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) | &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) |  |  |  |  | (2014) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | 7307 | 6775 | 6845 | 20722 | 19276 |
| Adjusted net income | Adjusted net income | $52423 | $45848 | $40236 | $146369 | $108000 |
| Diluted earnings per share, as reported | Diluted earnings per share, as reported | $1.64 | $1.41 | $0.91 | $4.39 | $2.53 |
| Non-GAAP per share adjustments: | Non-GAAP per share adjustments: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) | &nbsp;&nbsp;&nbsp;&nbsp;Restructuring costs, net of tax (1) |  |  | 0.30 | 0.15 | 0.72 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) | &nbsp;&nbsp;&nbsp;&nbsp;Other non-recurring income, net of tax (2) |  |  |  |  | (0.07) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation, net of tax | 0.26 | 0.25 | 0.24 | 0.75 | 0.69 |
| Adjusted diluted earnings per share | Adjusted diluted earnings per share | $1.90 | $1.66 | $1.45 | $5.29 | $3.87 |
| *(1)* | *During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's AMER region. <br>During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions. <br>During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.* | *During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's AMER region. <br>During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions. <br>During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.* | *During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's AMER region. <br>During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions. <br>During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.* | *During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's AMER region. <br>During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions. <br>During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.* | *During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's AMER region. <br>During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions. <br>During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.* | *During the three months ended June 29, 2024, restructuring and impairment charges of $9.2 million, or $8.3 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's AMER region. <br>During the nine months ended June 28, 2025, restructuring costs of $4.7 million, or $4.2 million net of taxes, were incurred primarily for employee severance costs associated with a reduction in the Company's workforce in the EMEA and AMER regions. <br>During the nine months ended June 29, 2024, restructuring costs of $22.5 million, or $20.1 million net of taxes, were incurred for employee severance costs associated with a reduction in the Company's workforce as well as closure costs associated with a site in the Company's EMEA region and with a site in the Company's AMER region.* |
| *(2)* | *During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.* | *During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.* | *During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.* | *During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.* | *During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.* | *During the nine months ended June 29, 2024, insurance proceeds of $2.3 million, or $2.0 million net of taxes, were received related to an arbitration decision associated with a contractual matter that occurred in the Company's EMEA region in fiscal 2023.* |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** | **PLEXUS CORP. AND SUBSIDIARIES** |
| **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** | **NON-GAAP SUPPLEMENTAL INFORMATION Table 2** |
| (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) | (in thousands) |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) | (unaudited) |
| **ROIC and Economic Return Calculations** | Nine Months Ended | Nine Months Ended | Six Months Ended | Six Months Ended | Nine Months Ended | Nine Months Ended |
|  | Jun 28, | Jun 28, | Mar 29, | Mar 29, | Jun 29, | Jun 29, |
|  | 2025 | 2025 | 2025 | 2025 | 2024 | 2024 |
| Operating income, as reported |  | $149259 |  | $95651 |  | $113874 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and other charges, net |  | 4683 |  | 4683 |  | 20257 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accelerated stock-based compensation (1) | + |  | + |  | + | 892 |
| Adjusted operating income |  | $153942 |  | $100334 |  | $135023 |
|  | ÷ | 3 | x | 2 | ÷ | 3 |
|  |  | $51314 |  |  |  | $45008 |
|  | x | 4 |  |  | x | 4 |
| Adjusted annualized operating income |  | $205256 |  | $200668 |  | $180032 |
| Adjusted effective tax rate | x | 11% | x | 13% | x | 16% |
| Tax impact |  | 22578 |  | 26087 |  | 28805 |
| Adjusted operating income (tax-effected) |  | $182678 |  | $174581 |  | $151227 |
| Average invested capital | ÷ | $1298575 | ÷ | $1276742 | ÷ | $1454871 |
| ROIC |  | 14.1% |  | 13.7% |  | 10.4% |
| Weighted average cost of capital | - | 8.9% | - | 8.9% | - | 8.2% |
| Economic return |  | 5.2% |  | 4.8% |  | 2.2% |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Average Invested Capital Calculations** | Jun 28, | Mar 29, | Dec 28, | Sep 28, |
|  | 2025 | 2025 | 2024 | 2024 |
| Equity | $1419085 | $1351675 | $1319069 | $1324825 |
| Plus: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - current | 50678 | 121014 | 121977 | 157325 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - current (2) | 8470 | 9968 | 14875 | 14697 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - long-term | 92215 | 88761 | 88728 | 89993 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - long-term | 31192 | 32720 | 35124 | 32275 |
| &nbsp;&nbsp;Less: Cash and cash equivalents | (237567) | (310531) | (317161) | (345109) |
|  | $1364073 | $1293607 | $1262612 | $1274006 |
| **Average Invested Capital Calculations** | Jun 29, | Mar 30, | Dec 30, | Sep 30, |
|  | 2024 | 2024 | 2023 | 2023 |
| Equity | $1266360 | $1259762 | $1266755 | $1214382 |
| Plus: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - current | 258175 | 245964 | 251119 | 240205 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - current (2) | 7990 | 8281 | 9172 | 8363 |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt and finance lease obligations - long-term | 90715 | 192025 | 192118 | 190853 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease obligations - long-term | 31923 | 33915 | 35989 | 38552 |
| &nbsp;&nbsp;Less: Cash and cash equivalents | (269868) | (265053) | (231982) | (256233) |
|  | $1385295 | $1474894 | $1523171 | $1436122 |

---

*(1)* *During the nine months ended June 29, 2024, $0.9 million of accelerated stock-based compensation expense was recorded in selling and administrative expense in the accompanying Condensed Consolidated Statements of Operations as a result of a previously announced executive retirement agreement.*

*(2)* *Included in other accrued liabilities on the Condensed Consolidated Balance Sheets.*